GC Biopharma

006280 · KOSPI · ₩006280 · 녹십자

₩132,000▲ ₩1,500 (1.15%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩2T₩1.7T₩1.6T₩1.7T₩1.5T
Cost of sales₩1.4T₩1.2T₩1.1T₩1.1T₩1T
Gross profit₩554B₩482B₩485B₩582B₩521B
Operating income₩69B₩32B₩34B₩81B₩74B
Net income−₩30B−₩43B−₩20B₩69B₩137B
Net income to shareholders−₩4.7B−₩26B−₩27B₩65B₩123B

Balance sheet

20252024202320222021
Total assets₩3T₩2.7T₩2.6T₩2.5T₩2.5T
Current assets₩1.4T₩1.2T₩1T₩980B₩1.1T
Cash and equivalents₩49B₩23B₩50B₩105B₩186B
Total liabilities₩1.6T₩1.3T₩1.1T₩959B₩962B
Current liabilities₩1.1T₩769B₩869B₩541B₩553B
Borrowings₩862B₩717B₩85B₩279B₩280B
Total equity₩1.4T₩1.5T₩1.5T₩1.6T₩1.5T
Shareholders' equity₩1.2T₩1.3T₩1.3T₩1.3T₩1.3T

Cash flow

20252024202320222021
Cash from operations₩99B−₩53B−₩5.5B₩119B₩126B
Capital spending₩72B₩32B₩79B₩58B₩102B
Free cash flow₩27B−₩85B−₩85B₩61B₩24B
Dividends paid₩19B₩20B₩25B₩24B₩19B

Consolidated where available. Amounts in won.

Also known as: GC Biopharma / 녹십자 / 006280 / KRX:006280

Source: KRX statistical information